Target intelligence / Profile preview

Macrophage polarization alteration

Molecular classification
Other
01

Overview

**Macrophage polarization alteration** refers to the process by which macrophages change or shift their functional phenotype in response to environmental stimuli, commonly classified as M1 (pro-inflammatory/classically activated) and M2 (anti-inflammatory/alternatively activated) phenotypes[3][6]. This process is controlled by a complex network of extracellular signals (e.g., cytokines, growth factors), ligand-receptor interactions (e.g., IFN-γ with its receptor for M1, IL-4/IL-13 with their receptor for M2), intracellular signaling pathways (JAK/STAT, NF-κB, PI3K/AKT), and transcriptional as well as epigenetic regulation[2][6][5][1]. Altered or imbalanced macrophage polarization is implicated in a wide array of diseases. Enhanced M1 polarization is associated with persistent inflammation and tissue damage (as seen in autoimmune disease, atherosclerosis, obesity), whereas excess M2 polarization is linked to tissue fibrosis, tumor progression, and impaired immune responses[1][3][6]. Macrophage polarization alteration is not a molecule or receptor, but a description of a dynamic cellular process involving many molecular actors. Therefore, it is not a conventional therapeutic target like a receptor, enzyme, or ion channel, but rather a biological phenomenon involving multiple upstream and downstream molecular targets[3][7]. **Caveat:** "Macrophage polarization alteration" is not a molecular entity, receptor, or canonical drug target. It describes a cellular process or state. While various receptors and signaling molecules (GM-CSFR, IFNGR, IL-4R, STATs, NF-κB, PPARγ, etc.) control macrophage polarization and are considered drug targets, the term itself is not a standardized or specific nomenclature for any therapeutic target[3][6][2][1]. Thus, is_incorrect: true applies—the entry describes a biological process, not a targetable molecule/receptor, and cannot be canonically mapped as requested.

Other names
Macrophage polarizationM1–M2 macrophage polarizationMacrophage phenotype switching
02

Biological functions

Immune responseInflammation regulationTissue remodelingWound healingAngiogenesisCell signaling
03

Disease associations

CancerInflammationFibrosisCardiovascular diseaseNeurodegenerative diseaseInfectionMetabolic disease
04

Biomarkers

Expression of specific M1 markers (e.g., CD80, CD86, TNF-α)M2 markers (e.g., CD206, CD163, IL-10, arginase 1)various cytokine levels (e.g., IL-6, IL-12, IL-23 for M1; IL-10, TGF-β for M2)

Beyond the preview

Go deeper on Macrophage polarization alteration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage polarization alteration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call